749660--3/23/2010--ICAD

related topics

{stock, price, share}

{product, liability, claim}

{customer, product, revenue}

{cost, regulation, environmental}

{control, financial, internal}

{product, market, service}

{product, candidate, development}

{stock, price, operating}

{condition, economic, financial}

{property, intellectual, protect}

{personnel, key, retain}

{tax, income, asset}

{acquisition, growth, future}

{operation, international, foreign}

{regulation, government, change}

We have incurred significant losses from inception through 2009 and there can be no assurance that we will be able to achieve and sustain future profitability. A limited number of customers account for a significant portion of our total revenues. The loss of a principal customer could seriously hurt our business. Disruptions in the capital and credit markets related to the current national and worldwide financial crisis, which may continue indefinitely or intensify, could adversely affect our results of operations, cash flows and financial condition, or those of our customers and suppliers. Our business is dependent upon future market growth of full field digital mammography systems and digital computer aided detection products as well as advanced image analysis and workflow solutions for use with MRI and CT. If goodwill and/or other intangible assets that we have recorded in connection with our acquisitions become impaired, we could have to take significant charges against earnings. We may not be able to obtain regulatory approval for any of the other products that we may consider developing. Our products and manufacturing facilities are subject to extensive regulation with potentially significant costs for compliance. Our products may be recalled even after we have received FDA or other governmental approval or clearance. Our quarterly operating and financial results and our gross margins are likely to fluctuate significantly in future periods. We may need additional financing to implement our strategy and expand our business. Changes in or non-reimbursement of procedures by Medicare or other third-party payers may adversely affect our business. We cannot be certain of the future effectiveness of our internal controls over financial reporting or the impact of the same on our operations or the market price for our common stock. Our business is subject to The Health Insurance Portability and Accountability Act of 1996, or HIPAA, and changes to or violations of these regulations could negatively impact our revenues. The markets for many of our products are subject to changing technology. We depend upon a limited number of suppliers and manufacturers for our products, and certain components in our products may be available from a sole or limited number of suppliers. We rely on intellectual property and proprietary rights to maintain our competitive position and may not be able to protect these rights. We may be exposed to significant product liability for which we may not be able to procure sufficient insurance coverage. Our future prospects depend on our ability to retain current key employees and attract additional qualified personnel. We distribute our products in highly competitive markets. Our international operations expose us to various risks, any number of which could harm our business. We do not anticipate paying cash dividends on our common stock. The market price of our common stock has been, and may continue to be, volatile which could reduce the market price of our common stock. Future sales of shares of our common stock may cause the prevailing market price of our shares to decrease and could harm our ability to raise additional capital.

Full 10-K form ▸

749660--3/23/2010--ICAD_INC